Bio-Path Holdings, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $37.0K | $13.0K | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $4.6M | $5.5M | $5.5M | $3.0M | $1.6M | $1.5M | $1.1M | — |
| SG&A Expense | $3.4M | $3.5M | $3.0M | $2.5M | $2.7M | $1.6M | $986.1K | $1.2M |
| Operating Income | $-8.6M | $-9.0M | $-8.5M | $-5.5M | $-4.5M | $-3.3M | $-2.6M | $-2.4M |
| Operating Margin | — | -24,232.4% | -65,192.3% | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-8.6M | $-7.0M | $-6.8M | $-5.5M | $-4.6M | $-3.3M | $-2.6M | $-2.4M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-8.6M | $-7.0M | $-6.8M | $-5.5M | $-4.5M | $-3.3M | $-2.6M | $-2.4M |
| Net Margin | — | -18,981.1% | -51,923.1% | — | — | — | — | — |
| EPS (Basic) | $-2.88 | $-3.20 | $-0.15 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EPS (Diluted) | $-2.88 | $-3.20 | $-0.15 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Shares Outstanding (Basic) | 3.4M | 2.8K | 478.2M | 448.8M | 448.8M | 421.2M | 311.1M | 291.6M |
| Shares Outstanding (Diluted) | 3.4M | 2.8K | 478.2M | 448.8M | 448.8M | 421.2M | 311.1M | 291.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |